中国防痨杂志 ›› 2023, Vol. 45 ›› Issue (9): 904-912.doi: 10.19982/j.issn.1000-6621.20230247
收稿日期:
2023-07-18
出版日期:
2023-09-10
发布日期:
2023-09-01
通信作者:
毕秀丽,Email:Bi Xiuli(), Geng Hong, Jin Jin
Received:
2023-07-18
Online:
2023-09-10
Published:
2023-09-01
Contact:
Bi Xiuli, Email:摘要:
宿主先天性和适应性免疫应答在对抗结核分枝杆菌(Mycobacterium tuberculosis,MTB)感染中发挥着重要作用,而耐药性的产生亦与免疫应答相关。研究发现,肺部髓系细胞能够对MTB产生免疫应答,在保护宿主和炎症产生过程中均有参与作用。适应性免疫应答中的多种细胞类型能对MTB感染产生免疫应答,其中抗原特异性CD4+T细胞在控制MTB感染中发挥着主要作用。然而,在复杂的MTB感染环境中,不同的髓系细胞和CD4+T细胞也可能是MTB感染的主要参与者,能够介导病理反应的发生。因此,本文就不同髓系细胞(主要包括单核细胞、巨噬细胞、树突状细胞)和CD4+ T细胞在MTB感染中的双重作用进行综述。
中图分类号:
毕秀丽, 耿红, 金瑾. 髓系细胞和CD4+ T细胞在结核分枝杆菌感染和免疫病理中的作用[J]. 中国防痨杂志, 2023, 45(9): 904-912. doi: 10.19982/j.issn.1000-6621.20230247
Bi Xiuli, Geng Hong, Jin Jin. The role of myeloid system and CD4+T cells in Mycobacterium tuberculosis infection and immunopathology[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 904-912. doi: 10.19982/j.issn.1000-6621.20230247
[1] |
Ogongo P, Tezera LB, Ardain A, et al. Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J Clin Invest, 2021, 131(10): e142014. doi:10.1172/JCI142014.
doi: 10.1172/JCI142014 URL |
[2] |
Van Dis E, Fox DM, Morrison HM, et al. IFN-gamma-independent control of M.tuberculosis requires CD 4 T cell-derived GM-CSF and activation of HIF-1alpha. PLoS Pathog, 2022, 18(7):e1010721. doi:10.1371/journal.ppat.1010721.
doi: 10.1371/journal.ppat.1010721 URL |
[3] |
Joshi N, Walter JM, Misharin AV. Alveolar Macrophages. Cell Immunol, 2018, 330:86-90. doi:10.1016/j.cellimm.2018.01.005.
doi: S0008-8749(18)30005-4 pmid: 29370889 |
[4] |
Huang L, Nazarova EV, Russell DG. Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage. Microbiol Spectr, 2019, 7(2):10. doi:10.1128/microbiolspec.BAI-0001-2019.
doi: 10.1128/microbiolspec.BAI-0001-2019 |
[5] |
Ufimtseva EG, Eremeeva NI, Umpeleva TV, et al. Mycobacterium tuberculosis Load in Host Cells and the Antibacterial Activity of Alveolar Macrophages Are Linked and Differentially Regulated in Various Lung Lesions of Patients with Pulmonary Tuberculosis. Int J Mol Sci, 2021, 22(7):3452. doi:10.3390/ijms22073452.
doi: 10.3390/ijms22073452 URL |
[6] |
Karanja CW, Yeboah KS, Sintim HO. Identification of a Mycobacterium tuberculosis Cyclic Dinucleotide Phosphodiesterase Inhibitor. ACS Infect Dis, 2021, 7(2):309-317. doi:10.1021/acsinfecdis.0c00444.
doi: 10.1021/acsinfecdis.0c00444 URL |
[7] |
Kim H, Shin SJ. Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion. Front Cell Infect Microbiol, 2022, 12:891878. doi:10.3389/fcimb.2022.891878.
doi: 10.3389/fcimb.2022.891878 URL |
[8] |
Pajuelo D, Gonzalez-Juarbe N, Tak U, et al. NAD+ Depletion Triggers Macrophage Necroptosis, a Cell Death Pathway Exploited by Mycobacterium tuberculosis. Cell Rep, 2018, 24(2):429-440. doi:10.1016/j.celrep.2018.06.042.
doi: S2211-1247(18)30952-5 pmid: 29996103 |
[9] |
Pisu D, Huang L, Narang V, et al. Single cell analysis of M.tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med, 2021, 218(9):e20210615. doi:10.1084/jem.20210615.
doi: 10.1084/jem.20210615 URL |
[10] |
Chen Q, Hu C, Lu W, et al. Characteristics of alveolar macro-phages in bronchioalveolar lavage fluids from active tuberculosis patients identified by single-cell RNA sequencing. J Biomed Res, 2022, 36(3):167-180. doi:10.7555/JBR.36.20220007.
doi: 10.7555/JBR.36.20220007 URL |
[11] |
Mariotti S, Pardini M, Gagliardi MC, et al. Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes. J Immunol, 2013, 191(1):274-282. doi:10.4049/jimmunol.1202900.
doi: 10.4049/jimmunol.1202900 pmid: 23733870 |
[12] |
Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J, 2009, 50(1):1-11. doi:10.3349/ymj.2009.50.1.1.
doi: 10.3349/ymj.2009.50.1.1 pmid: 19259342 |
[13] |
Repasy T, Lee J, Marino S, et al. Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis in vivo. PLoS Pathog, 2013, 9(2):e1003190. doi:10.1371/journal.ppat.1003190.
doi: 10.1371/journal.ppat.1003190 URL |
[14] |
Wolf AJ, Linas B, Trevejo-Nunez GJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol, 2007, 179(4):2509-2519. doi:10.4049/jimmunol.179.4.2509.
doi: 10.4049/jimmunol.179.4.2509 URL |
[15] |
Lafuse WP, Rajaram MVS, Wu Q, et al. Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to Mycobacterium tuberculosis Infection. J Immunol, 2019, 203(8):2252-2264. doi:10.4049/jimmunol.1900495.
doi: 10.4049/jimmunol.1900495 URL |
[16] |
Abdissa K, Nerlich A, Beineke A, et al. Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice. Front Immunol, 2018, 9:2317. doi:10.3389/fimmu.2018.02317.
doi: 10.3389/fimmu.2018.02317 pmid: 30386330 |
[17] |
Zhai W, Wu F, Zhang Y, et al. The Immune Escape Mechanisms of Mycobacterium Tuberculosis. Int J Mol Sci, 2019, 20(2):340. doi:10.3390/ijms20020340.
doi: 10.3390/ijms20020340 URL |
[18] |
Lai R, Jeyanathan M, Afkhami S, et al. CD11b+ Dendritic Cell-Mediated Anti-Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10. J Immunol, 2018, 200(5):1746-1760. doi:10.4049/jimmunol.1701109.
doi: 10.4049/jimmunol.1701109 |
[19] |
Mayer-Barber KD, Andrade BB, Barber DL, et al. Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity, 2011, 35(6):1023-1034. doi:10.1016/j.immuni.2011.12.002.
doi: 10.1016/j.immuni.2011.12.002 pmid: 22195750 |
[20] |
Kotze LA, Young C, Leukes VN, et al. Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts. EBioMedicine, 2020, 53:102670. doi:10.1016/j.ebiom.2020.102670.
doi: 10.1016/j.ebiom.2020.102670 URL |
[21] |
Akter S, Chauhan KS, Dunlap MD, et al. Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Rep, 2022, 39(12):110983. doi:10.1016/j.celrep.2022.110983.
doi: 10.1016/j.celrep.2022.110983 URL |
[22] |
Anderson KG, Mayer-Barber K, Sung H, et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc, 2014, 9(1):209-222. doi:10.1038/nprot.2014.005.
doi: 10.1038/nprot.2014.005 pmid: 24385150 |
[23] |
De Trez C, Magez S, Akira S, et al. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/ 6 resistant mice. PLoS Pathog, 2009, 5(6):e1000494. doi:10.1371/journal.ppat.1000494.
doi: 10.1371/journal.ppat.1000494 URL |
[24] |
Olson GS, Murray TA, Jahn AN, et al. Type I interferon decreases macrophage energy metabolism during mycobacterial infection. Cell Rep, 2021, 35(9):109195. doi:10.1016/j.celrep.2021.109195.
doi: 10.1016/j.celrep.2021.109195 URL |
[25] |
Thirunavukkarasu S, Ahmed M, Rosa BA, et al. Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J Clin Invest, 2023, 133(12):e158630. doi:10.1172/JCI158630.
doi: 10.1172/JCI158630 URL |
[26] |
Ravesloot-Chavez MM, Van Dis E, Stanley SA. The Innate Immune Response to Mycobacterium tuberculosis Infection. Annu Rev Immunol, 2021, 39:611-637. doi:10.1146/annu-rev-immunol-093019-010426.
doi: 10.1146/annurev-immunol-093019-010426 pmid: 33637017 |
[27] |
Cavalcante-Silva LHA, Almeida FS, Andrade AG, et al. Mycobacterium tuberculosis in a Trap: The Role of Neutrophil Extracellular Traps in Tuberculosis. Int J Mol Sci, 2023, 24(14):11385. doi:10.3390/ijms241411385.
doi: 10.3390/ijms241411385 URL |
[28] |
Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol, 2017, 14(12):963-975. doi:10.1038/cmi.2017.88.
doi: 10.1038/cmi.2017.88 URL |
[29] |
Moreira-Teixeira L, Stimpson PJ, Stavropoulos E, et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat Commun, 2020, 11(1):5566. doi:10.1038/s41467-020-19412-6.
doi: 10.1038/s41467-020-19412-6 pmid: 33149141 |
[30] |
Shah JA, Warr AJ, Graustein AD, et al. REL and BHLHE 40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk. J Immunol, 2022, 208(6):1352-1361. doi:10.4049/jimmunol.2100671.
doi: 10.4049/jimmunol.2100671 URL |
[31] |
Daniel L, Counoupas C, Bhattacharyya ND, et al. L-selectin-dependent and -independent homing of naive lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection. PLoS Pathog, 2023, 19(7):e1011460. doi:10.1371/journal.ppat.1011460.
doi: 10.1371/journal.ppat.1011460 URL |
[32] |
Blomgran R, Desvignes L, Briken V, et al. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD 4 T cells. Cell Host Microbe, 2012, 11(1):81-90. doi:10.1016/j.chom.2011.11.012.
doi: 10.1016/j.chom.2011.11.012 pmid: 22264515 |
[33] |
Sudbury EL, Clifford V, Messina NL, et al. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect, 2020, 81(6):873-881. doi:10.1016/j.jinf.2020.09.032.
doi: 10.1016/j.jinf.2020.09.032 pmid: 33007340 |
[34] |
Park HS, Choi S, Back YW, et al. Mycobacterium tuberculosis RpfE-Induced Prostaglandin E 2 in Dendritic Cells Induces Th1/Th17 Cell Differentiation. Int J Mol Sci, 2021, 22(14):7535. doi:10.3390/ijms22147535.
doi: 10.3390/ijms22147535 URL |
[35] |
Grant NL, Kelly K, Maiello P, et al. Mycobacterium tuberculosis-Specific CD 4 T Cells Expressing Transcription Factors T-Bet or RORgammaT Associate with Bacterial Control in Granulomas. mBio, 2023, 14(3):e0047723. doi:10.1128/mbio.00477-23.
doi: 10.1128/mbio.00477-23 URL |
[36] |
Negi S, Pahari S, Das DK, et al. Curdlan Limits Mycobacterium tuberculosis Survival Through STAT-1 Regulated Nitric Oxide Production. Front Microbiol, 2019, 10:1173. doi:10.3389/fmicb.2019.01173.
doi: 10.3389/fmicb.2019.01173 URL |
[37] |
Scanga CA, Mohan VP, Yu K, et al. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med, 2000, 192(3):347-358. doi:10.1084/jem.192.3.347.
doi: 10.1084/jem.192.3.347 pmid: 10934223 |
[38] |
Gallegos AM, van Heijst JW, Samstein M, et al. A gamma interferon independent mechanism of CD 4 T cell mediated control of M.tuberculosis infection in vivo. PLoS Pathog, 2011, 7(5):e1002052. doi:10.1371/journal.ppat.1002052.
doi: 10.1371/journal.ppat.1002052 URL |
[39] |
Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol, 2007, 19(6):377-382. doi:10.1016/j.smim.2007.10.009.
doi: 10.1016/j.smim.2007.10.009 pmid: 18054248 |
[40] |
Makatsa MS, Omondi FMA, Bunjun R, et al. Characterization of Mycobacterium tuberculosis-Specific Th 22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection. J Immunol, 2022, 209(3):446-455. doi:10.4049/jimmunol.2200140.
doi: 10.4049/jimmunol.2200140 pmid: 35777848 |
[41] |
Imperiale BR, Garcia A, Minotti A, et al. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis. Clin Exp Immunol, 2021, 203(2):267-280. doi:10.1111/cei.13544.
doi: 10.1111/cei.13544 pmid: 33128773 |
[42] |
Bryson BD, Rosebrock TR, Tafesse FG, et al. Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis. Nat Commun, 2019, 10(1):2329. doi:10.1038/s41467-019-10065-8.
doi: 10.1038/s41467-019-10065-8 pmid: 31133636 |
[43] |
Lovey A, Verma S, Kaipilyawar V, et al. Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains. Nat Commun, 2022, 13(1):884. doi:10.1038/s41467-022-28506-2.
doi: 10.1038/s41467-022-28506-2 |
[44] |
Hoft SG, Sallin MA, Kauffman KD, et al. The Rate of CD 4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors. Infect Immun, 2019, 87(6):e00841-18. doi:10.1128/IAI.00841-18.
doi: 10.1128/IAI.00841-18 |
[45] |
Grant NL, Maiello P, Klein E, et al. T cell transcription factor expression evolves over time in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques. Cell Rep, 2022, 39(7):110826. doi:10.1016/j.celrep.2022.110826.
doi: 10.1016/j.celrep.2022.110826 URL |
[46] |
Ferreira CM, Barbosa AM, Barreira-Silva P, et al. Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection. JCI Insight, 2021, 6(21):e150060. doi:10.1172/jci.insight.150060.
doi: 10.1172/jci.insight.150060 URL |
[47] |
Park HS, Back YW, Jang IT, et al. Mycobacterium tuberculosis Rv2145c Promotes Intracellular Survival by STAT3 and IL-10 Receptor Signaling. Front Immunol, 2021, 12:666293. doi:10.3389/fimmu.2021.666293.
doi: 10.3389/fimmu.2021.666293 URL |
[48] |
McCaffrey EF, Donato M, Keren L, et al. The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol, 2022, 23(2):318-329. doi:10.1038/s41590-021-01121-x.
doi: 10.1038/s41590-021-01121-x pmid: 35058616 |
[49] |
Singh M, Vaughn C, Sasaninia K, et al. Understanding the Relationship between Glutathione, TGF-beta, and Vitamin D in Combating Mycobacterium tuberculosis Infections. J Clin Med, 2020, 9(9):2757. doi:10.3390/jcm9092757.
doi: 10.3390/jcm9092757 URL |
[50] |
Cardona P, Cardona PJ. Regulatory T Cells in Mycobacterium tuberculosis Infection. Front Immunol, 2019, 10:2139. doi:10.3389/fimmu.2019.02139.
doi: 10.3389/fimmu.2019.02139 pmid: 31572365 |
[51] |
Stringari LL, Covre LP, da Silva FDC, et al. Increase of CD4+CD25highFoxP3+ cells impairs in vitro human microbicidal activity against Mycobacterium tuberculosis during latent and acute pulmonary tuberculosis. PLoS Negl Trop Dis, 2021, 15(7):e0009605. doi:10.1371/journal.pntd.0009605.
doi: 10.1371/journal.pntd.0009605 URL |
[52] |
Artola-Boran M, Fallegger A, Priola M, et al. Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells. Cell Rep, 2022, 38(6):110359. doi:10.1016/j.celrep.2022.110359.
doi: 10.1016/j.celrep.2022.110359 URL |
[53] |
Tonby K, Mortensen R, Ruhwald M, et al. KLRG1-Expressing CD 4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment. J Infect Dis, 2019, 220(1):174-176. doi:10.1093/infdis/jiz056.
doi: 10.1093/infdis/jiz056 URL |
[54] |
Hu Z, Zhao HM, Li CL, et al. The Role of KLRG 1 in Human CD4+ T-Cell Immunity Against Tuberculosis. J Infect Dis, 2018, 217(9):1491-1503. doi:10.1093/infdis/jiy046.
doi: 10.1093/infdis/jiy046 URL |
[55] |
Ogishi M, Yang R, Aytekin C, et al. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child. Nat Med, 2021, 27(9):1646-1654. doi:10.1038/s41591-021-01388-5.
doi: 10.1038/s41591-021-01388-5 pmid: 34183838 |
[56] |
Day CL, Abrahams DA, Bunjun R, et al. PD-1 Expression on Mycobacterium tuberculosis-Specific CD 4 T Cells Is Associated With Bacterial Load in Human Tuberculosis. Front Immunol, 2018, 9:1995. doi:10.3389/fimmu.2018.01995.
doi: 10.3389/fimmu.2018.01995 URL |
[57] |
Tezera LB, Bielecka MK, Ogongo P, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-alpha. Elife, 2020, 9:e52668. doi:10.7554/eLife.52668.
doi: 10.7554/eLife.52668 URL |
[1] | 陈瑞麒, 张明五, 王伟, 陈松华, 柳正卫, 陈彬. 浙江省常山县农村老年人结核分枝杆菌潜伏感染情况及影响因素[J]. 中国防痨杂志, 2024, 46(4): 383-389. |
[2] | 尚雪恬, 董静, 黄麦玲, 孙琦, 贾红彦, 张蓝月, 刘秋月, 姚明旭, 王颖超, 姬秀秀, 杜博平, 邢爱英, 潘丽萍. 结核分枝杆菌潜伏感染者外周血单个核细胞转录组学研究[J]. 中国防痨杂志, 2024, 46(4): 449-460. |
[3] | 姚阳阳, 梁长华, 韩东明, 崔俊伟, 潘犇, 王慧慧, 魏正琦, 甄思雨, 危涵羽. 基于CT影像组学结合临床特征鉴别肺结核与非结核分枝杆菌肺病的研究[J]. 中国防痨杂志, 2024, 46(3): 302-310. |
[4] | 张静, 付若楠, 王森路, 冯建宇, 张玲, 古丽娜·巴德尔汗, 祖力卡提阿衣·阿布都拉, 王新旗. 高负担地区肺结核密切接触者中结核分枝杆菌潜伏感染者预防性治疗接受意愿及影响因素研究[J]. 中国防痨杂志, 2024, 46(2): 165-172. |
[5] | 姜晓颖, 刘静, 张治国, 张文, 高孟秋, 杨新婷, 弭凤玲. 196例初治病原学阳性肺结核患者结核感染控制知识知晓情况调查[J]. 中国防痨杂志, 2024, 46(2): 213-220. |
[6] | 尚雪恬, 潘丽萍. 组织激肽释放酶家族在病原微生物感染中的作用[J]. 中国防痨杂志, 2024, 46(2): 239-244. |
[7] | 何翼君, 成君, 高磊. 循序渐进:系统性开展结核分枝杆菌潜伏感染流行病学调查[J]. 中国防痨杂志, 2024, 46(1): 1-7. |
[8] | 王佳妮, 席明霞. 结核病灾难性卫生支出的研究进展[J]. 中国防痨杂志, 2024, 46(1): 112-118. |
[9] | 张丽帆, 马亚楠, 邹小青, 张月秋, 张奉春, 曾小峰, 赵岩, 刘升云, 左晓霞, 吴华香, 武丽君, 李鸿斌, 张志毅, 陈盛, 朱平, 张缪佳, 齐文成, 刘毅, 刘花香, 侍效春, 刘晓清, 中国风湿免疫病人群活动性结核病的流行病学调查和治疗效果及预后研究课题组. 风湿免疫病患者结核分枝杆菌潜伏感染率及相关影响因素的多中心横断面研究[J]. 中国防痨杂志, 2024, 46(1): 29-39. |
[10] | 杜毓, 张海鹏, 王鹏. 分枝杆菌噬菌体的研究现状及应用进展[J]. 中国防痨杂志, 2023, 45(9): 897-903. |
[11] | 李依奇, 柳永明, 陈耀龙, 杨引君, 刘贝, 温发延, 李岩. 布鲁氏菌性脊柱炎动物模型研究进展[J]. 中国防痨杂志, 2023, 45(9): 913-920. |
[12] | 郭同磊, 辛赫男, 高磊. 《世界卫生组织结核病整合指南模块1:结核病预防性治疗》解读[J]. 中国防痨杂志, 2023, 45(8): 723-727. |
[13] | 汪敏, 袁园, 谭守勇, 杨子龙, 冯治宇, 张宏, 吴迪, 陈泽莹, 黄显林, 邝浩斌. 2型糖尿病合并初治菌阳肺结核患者肺部广泛病灶和空洞发生的危险因素分析[J]. 中国防痨杂志, 2023, 45(8): 761-767. |
[14] | 王涵飞, 赵雁林, 徐彩红. 亚临床结核病研究进展[J]. 中国防痨杂志, 2023, 45(8): 808-813. |
[15] | 王庆, 丁彩红, 高绪胜, 解丹, 蒋培培, 熊瑜. 含贝达喹啉方案治疗非结核分枝杆菌病三例[J]. 中国防痨杂志, 2023, 45(8): 814-817. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||